Evaluation of overexpression of VEGF mRNA of pancreatic cancer using surgical and endoscopic samples obtained with EUS-FNA

Evaluation of overexpression of VEGF mRNA of pancreatic cancer using surgical and endoscopic samples obtained with EUS-FNA - The expression of VEGF mRNA of pancreatic cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007994

Enrollment

Registered

2012-05-21

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Evaluation of VEGF mRNA and protein

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.The patients who are suspected of pancreatic cancer and have a plan to take the examination of EUS-FNA. 2.Performance status; 0,1,2

Exclusion criteria

Exclusion criteria: 1.The patients who take anticoagulants 2.The patients with acute pancreatitis 3.The patient who have already take chemotherapy or radiotherapy 4.The patients who are pregnant

Design outcomes

Primary

Measure	Time frame
Evaluation of VEGF of pancreatic cancer using surgical and endoscopic samples	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026